Not registered yet? Get a free account.

Sign Up
search icon cancel icon
Glenmark Pharmaceuticals Limited Location T. Score Charges People Network Registered Details
We are excited to bring you Tofler 2.0! Being new, there might be a few hiccups. Please bear with us.

GLENMARK PHARMACEUTICALS LIMITED

www.glenmarkpharma.com
Active
Updated: 24 Oct 2024

The company develops, manufactures, and markets pharmaceutical products in India, the United States, Latin America, Europe, and internationally. The company provides branded and generic formulations in therapeutic areas of dermatology, respiratory, and oncology.

Glenmark Pharmaceuticals Limited, is a listed public company incorporated on 18 November, 1977. It is classified as a public limited company and is located in Mumbai, Maharashtra. It's authorized share capital is INR 277.00 cr and the total paid-up capital is INR 28.22 cr.

Read more

Industry

Manufacturing of Pharmaceuticals
Products
  • GBR 1302 for breast and gastric cancer; GBR 1342 for multiple myeloma; GBR 1372 for colorectal cancer; GBR 830 for atopic dermatitis; GRC 39815 for COPD and IPF; Ryaltris for allergic rhinitis; GSP 304 for COPD; GBR 310 for Asthma and CIU; and GRC 27864 for chronic pain indications
Key Metrics

** All rupee values in INR crores. Based on March 2023 numbers.

Sales
0.97%
₹ GET PRO
EBITDA
-12.76%
₹ GET PRO
Net Profit
-39.49%
₹ GET PRO
Networth
6.8%
₹ GET PRO
Borrowings
-14.0%
₹ GET PRO
Assets
7.29%
₹ GET PRO
Gross Margin
1.17
GET PRO%
Operating Margin
-2.82
GET PRO%
Net Profit Margin
-9.69
GET PRO%
Return on Equity
-5.18
GET PRO%
ROCE
-5.81
GET PRO%
Debt to Equity
-0.04
GET PRO
Sales
Mar 2023
Net worth
Mar 2023

Locations

indian flag India (43)
State Type Address

location icon Locations on Map

Map placeholder

Tofler Score

score img
Poor
Fair
Good
Very Good
Excellent

Risk

Severe Risk
  • No risks identified
Moderate Risk
  • No risks identified
Low Risk
  • No risks identified
About Tofler Score
Tofler Score measures the quality of performance and integrity of a company. It is dependent on three key factors - Sustainability, Governance, and Growth.

Read more

Financial Highlights

** All numbers in INR crores
Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Sales GET PRO GET PRO GET PRO GET PRO GET PRO
Operating profit GET PRO GET PRO GET PRO GET PRO GET PRO
Net profit GET PRO GET PRO GET PRO GET PRO GET PRO
Gross margin GET PRO GET PRO GET PRO GET PRO GET PRO
Operating margin GET PRO GET PRO GET PRO GET PRO GET PRO
Net margin GET PRO GET PRO GET PRO GET PRO GET PRO
Networth
Borrowings GET PRO GET PRO GET PRO GET PRO GET PRO
Assets GET PRO GET PRO GET PRO GET PRO GET PRO
Debt to equity GET PRO GET PRO GET PRO GET PRO GET PRO
Current ratio GET PRO GET PRO GET PRO GET PRO GET PRO
ROE GET PRO GET PRO GET PRO GET PRO GET PRO
Days payable GET PRO GET PRO GET PRO GET PRO GET PRO
WC days GET PRO GET PRO GET PRO GET PRO GET PRO
chart icon

Margins

Gross margin
Operating margin
Net margin

Balance Sheet

%
** All numbers in INR crores
Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity Capital GET PRO GET PRO GET PRO GET PRO GET PRO
Reserves GET PRO GET PRO GET PRO GET PRO GET PRO
Borrowings + GET PRO GET PRO GET PRO GET PRO GET PRO
Long term borrowings GET PRO GET PRO GET PRO GET PRO GET PRO
Short term borrowings GET PRO GET PRO GET PRO GET PRO GET PRO
Trade payables + GET PRO GET PRO GET PRO GET PRO GET PRO
Days payable GET PRO GET PRO GET PRO GET PRO GET PRO
Other liabilities + GET PRO GET PRO GET PRO GET PRO GET PRO
Other non-current liabilities GET PRO GET PRO GET PRO GET PRO GET PRO
Other current liabilities GET PRO GET PRO GET PRO GET PRO GET PRO
Total liabilities GET PRO GET PRO GET PRO GET PRO GET PRO
Fixed Assets + GET PRO GET PRO GET PRO GET PRO GET PRO
Tangible assets GET PRO GET PRO GET PRO GET PRO GET PRO
CWIP GET PRO GET PRO GET PRO GET PRO GET PRO
Intangible assets GET PRO GET PRO GET PRO GET PRO GET PRO
LT loans and advances GET PRO GET PRO GET PRO GET PRO GET PRO
Other non-current assets GET PRO GET PRO GET PRO GET PRO GET PRO
Current assets + GET PRO GET PRO GET PRO GET PRO GET PRO
Inventories GET PRO GET PRO GET PRO GET PRO GET PRO
Trade receivables GET PRO GET PRO GET PRO GET PRO GET PRO
Cash and cash equivalents GET PRO GET PRO GET PRO GET PRO GET PRO
ST loans and advances GET PRO GET PRO GET PRO GET PRO GET PRO
Other current assets GET PRO GET PRO GET PRO GET PRO GET PRO
Total assets GET PRO GET PRO GET PRO GET PRO GET PRO
chart icon

Total assets

Profit & Loss

%
** All numbers in INR crores
Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Sales + GET PRO GET PRO GET PRO GET PRO GET PRO
Sales growth % GET PRO GET PRO GET PRO GET PRO GET PRO
Expenses + GET PRO GET PRO GET PRO GET PRO GET PRO
Cost of goods GET PRO GET PRO GET PRO GET PRO GET PRO
Employee cost GET PRO GET PRO GET PRO GET PRO GET PRO
Other costs GET PRO GET PRO GET PRO GET PRO GET PRO
Operating profit + GET PRO GET PRO GET PRO GET PRO GET PRO
Operating margin % GET PRO GET PRO GET PRO GET PRO GET PRO
Other income GET PRO GET PRO GET PRO GET PRO GET PRO
Interest GET PRO GET PRO GET PRO GET PRO GET PRO
Depreciation GET PRO GET PRO GET PRO GET PRO GET PRO
Exceptional items GET PRO GET PRO GET PRO GET PRO GET PRO
Profit before tax GET PRO GET PRO GET PRO GET PRO GET PRO
Tax GET PRO GET PRO GET PRO GET PRO GET PRO
Profit - disc. ops GET PRO GET PRO GET PRO GET PRO GET PRO
Net profit GET PRO GET PRO GET PRO GET PRO GET PRO
Net margin % GET PRO GET PRO GET PRO GET PRO GET PRO
chart icon

Revenue from operations

Ratios

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Solvency +
Total Debt/Equity GET PRO GET PRO GET PRO GET PRO GET PRO
Net Debt/Equity GET PRO GET PRO GET PRO GET PRO GET PRO
Total Debt/Assets GET PRO GET PRO GET PRO GET PRO GET PRO
Total Assets/Equity GET PRO GET PRO GET PRO GET PRO GET PRO
Liquidity +
Current Ratio GET PRO GET PRO GET PRO GET PRO GET PRO
Quick Ratio GET PRO GET PRO GET PRO GET PRO GET PRO
Interest Coverage GET PRO GET PRO GET PRO GET PRO GET PRO
Performance
Gross Margin GET PRO GET PRO GET PRO GET PRO GET PRO
Operating Margin GET PRO GET PRO GET PRO GET PRO GET PRO
Net Margin GET PRO GET PRO GET PRO GET PRO GET PRO
Return +
Return on Equity GET PRO GET PRO GET PRO GET PRO GET PRO
Pre-tax ROCE GET PRO GET PRO GET PRO GET PRO GET PRO
Return on Assets GET PRO GET PRO GET PRO GET PRO GET PRO
Pre-tax ROIC GET PRO GET PRO GET PRO GET PRO GET PRO
Efficiency +
Days Payable GET PRO GET PRO GET PRO GET PRO GET PRO
Days Inventory GET PRO GET PRO GET PRO GET PRO GET PRO
Days Receivable GET PRO GET PRO GET PRO GET PRO GET PRO
Fixed Asset Turnover GET PRO GET PRO GET PRO GET PRO GET PRO
Total Asset Turnover GET PRO GET PRO GET PRO GET PRO GET PRO
Working Capital
Cash Conversion Cycle GET PRO GET PRO GET PRO GET PRO GET PRO
Working Capital Days GET PRO GET PRO GET PRO GET PRO GET PRO
chart icon

Ratios

Current ratio
Debt/equity ratio

Charges on assets

Bank wise
Charges
1

Bank of India

No. of Loans: 1

Total Amount : 890.0 cr

chart icon

Charges

Bank of India

People

Designation Name DIN/PAN Tenure
Director Blanche Saldanha Elizabeth
Shareholder
00007671 15 years
Director Rajesh Vasudeo Desai
Shareholder
00007960 22 years
Managing Director Glenn Mario Saldanha
Shareholder
00050607 26 years
Whole-time Director Cherylann Maria Pinto
Shareholder
00111844 17 years
CFO V S Mani
Shareholder
<HIDDEN> 7 years
Whole-time Director V S Mani
Shareholder
01082878 6 years
Director Vijayalakshmi Iyer 05242960 2 years
Director Sona Saira Ramasastry 08398547 6 years
Director Dipankar Bhattacharjee 08770548 4 years
CS Harish Vinayak Kuber <HIDDEN> 8 years

Company Network

Companies connected through Directors

Name Status Paid up Capital Common Directors Address
GM PHARMA LIMITED
Amalgamated
10.0 L 2 Maharashtra
GLENMARK ACCESS LIMITED
Amalgamated
1.9 Cr 3 Maharashtra
GLENMARK GENERICS LIMITED
Amalgamated
151.1 Cr 2 Maharashtra
DESVEN CONSULTANTS PRIVATE LIMITED
Active
1.0 L 1 Maharashtra
QI LIFECARE PRIVATE LIMITED CN
Active
4.0 Cr 1 Maharashtra
DORF-KETAL CHEMICALS INDIA LIMITED
Active
246.8 Cr 1 Gujarat
GLENMARK HEALTHCARE LIMITED
Active
9.1 Cr 3 Maharashtra
BFSI SECTOR SKILL COUNCIL OF INDIA
Active
2.0 Cr 1 Maharashtra
COMPUTER AGE MANAGEMENT SERVICES LIMITED
Active
49.2 Cr 1 Tamil Nadu
AXIS MUTUAL FUND TRUSTEE LIMITED
Active
5.0 L 1 Maharashtra
GAWAR INVESTMENT MANAGER PRIVATE LIMITED
Active
13.0 Cr 1 Haryana
AVANSE FINANCIAL SERVICES LIMITED
Active
125.9 Cr 1 Maharashtra
L&T METRO RAIL (HYDERABAD) LIMITED
Active
7,413.0 Cr 1 Telangana
ICICI SECURITIES LIMITED
Active
162.0 Cr 1 Maharashtra
ADITYA BIRLA CAPITAL LIMITED
Active
2,605.2 Cr 1 Gujarat
CG POWER AND INDUSTRIAL SOLUTIONS LIMITED
Active
305.7 Cr 1 Maharashtra

Subsidiary Companies

Name State / Country Incorporation Year Paidup Capital
Glenmark Holding SA Switzerland - -
Glenmark Pharmaceuticals S.A., Switzerland Switzerland - -
Glenmark Farmaceutica Ltda. Brazil - -
Glenmark Pharmaceutical SRO Czech Republic - -
Glenmark Pharmaceutical SK SRO Slovakia - -
Glenmark Pharmaceutical SRL Romania - -
Glenmark Pharmaceuticals (Europe) R&D Ltd. United Kingdom - -
Glenmark Therapeutics Inc., USA United States - -
Glenmark Pharmaceuticals SP Z.O.O. Poland - -
Glenmark-Pharmaceuticals Ecuador S.A. Ecuador - -
Glenmark South Africa (pty) Ltd South Africa - -
Glenmark Pharmaceuticals South Africa (pty) Ltd. South Africa - -
Glenmark Impex L.L.C. Russian Federation - -
Glenmark Pharmaceuticals (Nigeria) Ltd Nigeria - -
Glenmark Dominicana SRL Dominican Republic - -
Glenmark Pharmaceuticals (Australia) Pty Ltd. Australia - -
Glenmark Pharmaceuticals (Malaysia) SDN.BHD Malaysia - -
Glenmark Philippines Inc. Philippines - -
Glenmark Pharmaceuticals Egypt SAE Egypt - -
Glenmark Pharmaceuticals FZE United Arab Emirates - -
Glenmark Uruguay SA Uruguay - -
Glenmark Pharmaceuticals Mexico, S.A DECV. Mexico - -
Glenmark Pharmaceuticals Peru SAC. Peru - -
Glenmark Pharmaceuticals Venezuela , CA Venezuela, Bolivarian Republic Of - -
Glenmark Pharmaceuticals Colombia SAS Colombia - -
Glenmark Pharmaceuticals Europe Ltd. United Kingdom - -
Glenmark Pharmaceuticals Inc. USA United States - -
Glenmark Generics SA Argentina Argentina - -
Glenmark Pharmaceuticals B.V. Netherlands - -
Glenmark Arzneimittel GmBH Germany - -
Glenmark Pharmaceuticals Canada INC Canada - -
Glenmark Pharmaceuticals (Kenya) Limited Kenya - -
Glenmark Ttherapeutics AG Switzerland - -
Glenmark Pharmaceuticals Distribution SRO Czech Republic - -
Glenmark Specialty SA Switzerland - -
Viso Farmaceutica SLU Spain - -
Glenmark Pharmaceuticals (Thailand) Co. Ltd. Thailand - -
Glenmark Pharmaceuticals Nordic AB Sweden - -
Glenmark Ukraine LLC Ukraine - -

Registered Details

CIN

L24299MH1977PLC019982

PAN

AAACG2207L

Incorporation

1977, 47.0 years

Company Email

complianceofficer@glenmarkpharma.com

Paid up Capital

₹ 28.2 Cr

Authorised Capital

₹ 277.0 Cr

AGM

31 Jun 2024

Type

Public
Non-government Company

Last Balance Sheet Date
Reconfirm refresh img

Mar 2023 Updated on : 24 Oct 2024
* There is the date provided by MCA, but availability for this year is not guaranteed.

FAQ - GLENMARK PHARMACEUTICALS LIMITED

What is the incorporation date of GLENMARK PHARMACEUTICALS LIMITED?

plus icon

The incorporation date of GLENMARK PHARMACEUTICALS LIMITED is 18 November, 1977

What is the authorized share capital of GLENMARK PHARMACEUTICALS LIMITED?

plus icon

The authorized share capital of GLENMARK PHARMACEUTICALS LIMITED is INR ₹ 277.0 Cr.

What is the paid-up capital of GLENMARK PHARMACEUTICALS LIMITED?

plus icon

The paid-up capital of GLENMARK PHARMACEUTICALS LIMITED is INR ₹ 28.2 Cr.

What is the registered address of GLENMARK PHARMACEUTICALS LIMITED?

plus icon

The registered address of GLENMARK PHARMACEUTICALS LIMITED is B-2MAHALAXMI CHAMBERS22 BHULABHAI DESAI ROAD MAHALAXMI NA MUMBAI Maharashtra - 400026

What is the CIN number of GLENMARK PHARMACEUTICALS LIMITED?

plus icon

The CIN number of GLENMARK PHARMACEUTICALS LIMITED is L24299MH1977PLC019982.

Smart Suggestions

  • Uttar Pradesh
  • Haryana
  • Jammu & Kashmir
  • Punjab
  • Goa
  • Madhya Pradesh
  • Kerala
  • Gujarat
  • Andhra Pradesh
  • Telangana
  • Blog Categories
  • Top Blog post
  • Financial Resources
Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to... Read More